A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

NCT00743847 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: placebo
DRUG: varenicline
DRUG: varenicline

Sponsor

Pfizer